Metraipolis › archive › dc_eca199d8668b

Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy — Europe PMC PMID:42515025

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42515025
DOI
10.3390/pathogens15070698
License (as archived)
solo-consultazione
Archived
2026-10-08T08:29:26.591Z
SHA-256 of the archived text
7bc93b16a5bd5860c1123ce17dc357a1b9be8be496baed778bd47fa269d6e361
Stable URL of this page
https://metraipolis.com/documento/dc_eca199d8668b

How to cite

Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy — Europe PMC PMID:42515025 — Europe PMC (en), https://europepmc.org/article/MED/42515025 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eca199d8668b (Metraipolis archive dc_eca199d8668b, sha256 7bc93b16a5bd5860c1123ce17dc357a1b9be8be496baed778bd47fa269d6e361)
BibTeX
@misc{dceca199d8668b,
  title = {Impact of Universal Nirsevimab Immunoprophylaxis on RSV-Related Hospitalizations in Infants: A Two-Season Multicenter Study in Northern Italy — Europe PMC PMID:42515025},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42515025},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eca199d8668b; sha256 7bc93b16a5bd5860c1123ce17dc357a1b9be8be496baed778bd47fa269d6e361},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42515025. Agents can read the archived copy with the MCP tool read_document.